Novo Nordisk A/S (NVO)
126.16
-2.48
(-1.93%)
USD |
NYSE |
Apr 24, 16:00
124.30
-1.86
(-1.47%)
Pre-Market: 05:02
Novo Nordisk Gross Profit (Quarterly): 8.060B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.060B |
September 30, 2023 | 7.158B |
June 30, 2023 | 6.788B |
March 31, 2023 | 6.516B |
December 31, 2022 | 5.475B |
September 30, 2022 | 5.194B |
June 30, 2022 | 5.039B |
March 31, 2022 | 5.297B |
December 31, 2021 | 4.936B |
September 30, 2021 | 4.687B |
June 30, 2021 | 4.456B |
March 31, 2021 | 4.538B |
December 31, 2020 | 4.248B |
September 30, 2020 | 4.049B |
June 30, 2020 | 3.727B |
March 31, 2020 | 4.206B |
December 31, 2019 | 4.000B |
September 30, 2019 | 3.754B |
June 30, 2019 | 3.789B |
March 31, 2019 | 3.738B |
December 31, 2018 | 3.834B |
September 30, 2018 | 3.641B |
June 30, 2018 | 3.694B |
March 31, 2018 | 3.750B |
December 31, 2017 | 3.686B |
Date | Value |
---|---|
September 30, 2017 | 3.531B |
June 30, 2017 | 3.583B |
March 31, 2017 | 3.467B |
December 31, 2016 | 3.575B |
September 30, 2016 | 3.531B |
June 30, 2016 | 3.555B |
March 31, 2016 | 3.397B |
December 31, 2015 | 3.559B |
September 30, 2015 | 3.417B |
June 30, 2015 | 3.435B |
March 31, 2015 | 3.230B |
December 31, 2014 | 3.454B |
September 30, 2014 | 3.347B |
June 30, 2014 | 3.300B |
March 31, 2014 | 3.098B |
December 31, 2013 | 3.339B |
September 30, 2013 | 3.019B |
June 30, 2013 | 3.114B |
March 31, 2013 | 2.898B |
December 31, 2012 | 3.097B |
September 30, 2012 | 2.747B |
June 30, 2012 | 2.770B |
March 31, 2012 | 2.530B |
December 31, 2011 | 2.716B |
September 30, 2011 | 2.519B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
3.727B
Minimum
Jun 2020
8.060B
Maximum
Dec 2023
5.048B
Average
4.687B
Median
Sep 2021
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 5.084B |
AstraZeneca PLC | 9.716B |
Sanofi SA | 8.780B |
Viking Therapeutics Inc | -- |
Evaxion Biotech AS | -- |